SCHEMBL24110342

SCHEMBL24110342

CC(C)C(C(=O)n1ccc2cc(F)ccc21)N(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TFPI2 P48307 1/20 0.42
HTR2A P28223 3/20 0.42
HTR2C P28335 3/20 0.42
HTR7 P34969 1/20 0.39
KCNH2 Q12809 1/20 0.39
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
HPGD P15428 1/20 0.38
HSD17B10 Q99714 1/20 0.38
FABP4 P15090 1/20 0.37
PPARG P37231 4/20 0.36
DPP4 P27487 1/20 0.34
DPP8 Q6V1X1 1/20 0.34
DPP9 Q86TI2 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
SLC6A2 P23975 2/20 0.34
SLC6A4 P31645 2/20 0.34
SIGMAR1 Q99720 1/20 0.34
NPY5R Q15761 1/20 0.34
GRM4 Q14833 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24110358 1.00 TFPI2 (0.42) TFPI2HTR2AHTR2CHTR7KCNH2
SCHEMBL24110373 1.00 TFPI2 (0.42) TFPI2HTR2AHTR2CHTR7KCNH2
SCHEMBL24110490 0.86 HTR2A (0.43) TFPI2HTR2AHTR2CHTR7KCNH2
SCHEMBL24109788 0.86 HTR2A (0.43) TFPI2HTR2AHTR2CHTR7KCNH2
SCHEMBL24110329 0.86 HTR2A (0.43) TFPI2HTR2AHTR2CHTR7KCNH2
SCHEMBL24109947 0.82 TUBB1 (0.51) TFPI2HTR2CKDM4EALDH1A1HPGD
SCHEMBL25818679 0.82 MAOB (0.35) TFPI2HTR2CKDM4EPPARGGRM4
SCHEMBL24109789 0.82 TUBB1 (0.51) TFPI2HTR2CKDM4EALDH1A1HPGD
SCHEMBL25818760 0.80 HTR2C (0.52) TFPI2HTR2AHTR2CHTR7KCNH2
SCHEMBL24110338 0.77 HTR2A (0.44) TFPI2HTR2AHTR2CHTR7KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. 2023-07-13 US disclosed
WO-2021252692-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF DELIX THERAPEUTICS, INC. (US) 2021-12-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230219969-A1 ISOTRYPTAMINE PSYCHOPLASTOGENS AND USES THEREOF GAP43, SLC18A2, PNMT TFPI2 3990/4885HTR2A 10/4885HTR2C 35/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.